This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Lenvatinib + Pembro vs. Sunitinib in aRCC - Patterns of Progression and Subsequent Therapy in the CLEAR Trial"

121 views
June 11, 2024

Chapters

CLEAR Study: Len-Pem vs. Sunitinib Efficacy

00:00

Subsequent Therapies & Tumor Burden Analysis

01:49

Comments 0
Login to view comments. Click here to Login